• Mashup Score: 7
    FDA issues final guidance - 12 month(s) ago

    This final guidance describes the agency’s current recommendations regarding adjusting for covariates in the statistical analysis of randomized clinical trials in drug and biological product development programs.

    Tweet Tweets with this article
    • RT @triadsou: FDA issues final guidance on adjusting for covariates in randomized clinical trials https://t.co/B77EmXRmuN

  • Mashup Score: 2
    PSI - 2 year(s) ago

    The community dedicated to leading and promoting the use of statistics within the healthcare industry for the benefit of patients.

    Tweet Tweets with this article
    • RT @tmorris_mrc: PSI webinar on covariate adjustment in trials. 1st Dec, 13:00–16:00 GMT. Come along! https://t.co/O3bZFIQfvK https://t.co/…

  • Mashup Score: 13

    Carnegie Mellon has four defensive touchdowns, two shutouts and has held three other teams below 10 points. That’s just part of how the Tartans are off to an 8-0 start. Brian Lester has more.

    Tweet Tweets with this article
    • RT @TartanFB: From @d3football: Streaking Tartans doing it with defense. #d3fb https://t.co/ADKlnYeyoz

  • Mashup Score: 0

    Editorial Notes As Sander Greenland has so well stated below, this initial draft was still too “dichotomous” in that it was written assuming we would have different language for “positive” vs. “negative” studies. This implies a threshold for “positive” which is what we’re trying to get away from. So I’m trying to develop more “positive/negative agnostic” language. One initial stab at this is…

    Tweet Tweets with this article
    • @dr_benoy_n_shah But there’s a whole bunch of virtual ink spilled (eg here: https://t.co/7t1AE3WTUp) where some very smart people advocate for language an awful lot like the conclusion that has everyone so mad.